Police May Soon Scan Your Eye to See if You’ve Consumed Cannabis

A novel device for testing people under the influence of cannabis developed by technology company Montana Gaize, Inc. has detected irregular eye movements in hundreds of people who consumed cannabis in a recent clinical trial.

For more of the latest cannabis innovations and research, download our free cannabis news app.

Clinical Trial of Eye Scanning Device

Gaize, Inc. announced that it had completed a clinical trial in which VR goggles were used to test whether participants were under the influence of cannabis. The study involving 350 participants used Gaize’s portable and non-invasive testing device to examine eye movement and pupil reflex changes.

Cannabis use has skyrocketed in recent years as more and more countries have legalized it for medical and recreational purposes, and its general acceptance in society has grown. However, until now there has been no device capable of detecting whether a person is under the influence of cannabis. Moreover, the exact characteristics of eye movement and the changes that occur due to intoxication have not been adequately studied.

Eye Scanning Addresses Deficiencies in Current Tests

Current methods of testing drivers can detect THC in a person’s body several weeks after use, but are unable to determine whether they are currently under the influence.

“The eyes are the mirror of the soul. The eyes give an obvious picture of a person’s mental state. They are full of involuntary micro-movements and reflexes that convey information about someone’s sobriety or lack thereof,” reads Gaize’s website.

Eye Scanning Can’t Currently Be Used as Evidence in Courts

According to the company’s founder, Ken Fichtler, the scan can’t be used as evidence in court like a traditional breathalyzer. Still, police officers can use it in the field if they suspect someone is under the influence of cannabis to eliminate their own biases completely.

Gaize’s technology can’t yet quantify the amount of cannabis consumed like a traditional breathalyzer does. Still, in principle, it can indicate whether a person is sufficiently intoxicated that their eye reacts differently to the stimulus than normal.

“You can’t just measure THC and say, ‘Yeah, okay, this guy is high because he has five nanograms of THC in his system, right?’ It just doesn’t work that way,” – Fichtler said.

Release By Year-End 2022

Gaize plans to release the flagship product by the end of 2022, and is currently taking objections from law enforcement and safety-critical companies.

“We really tested our cannabis impairment product. Based on the data we collected, we were able to capture important insights into how the eyes of people under the influence of cannabis behave,” said Rob Lass, chief technology officer at the eye scannabis tech company.

“The impact this device can have on safety both on the road and in the workplace is extremely exciting for me and everyone at the company! We are very proud to have been a part of this and can’t wait to see the positive changes this device will bring around the world,” – added Peter Wojewnik, a partner at a contract research firm.

—

(Featured image by Victor Freitas via Pexels)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.